Gene · 6595
Papers3,459
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,459
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Paraspeckles interact with SWI/SNF subunit ARID1B to regulate transcription and splicing. | EMBO Rep | 2023 | 36354291 | PubTator, text mining | PubMed |
| Malignant undifferentiated epithelioid neoplasms with MAML2 rearrangements: A clinicopathologic study of seven cases demonstrating a heterogenous entity. | Genes Chromosomes Cancer | 2023 | 36344258 | PubTator, text mining | PubMed |
| The bromodomain protein TRIM28 controls the balance between growth and invasiveness in melanoma. | EMBO Rep | 2023 | 36341538 | PubTator, text mining | PubMed |
| Extranodal T- and NK-cell lymphomas. | Virchows Arch | 2023 | 36336765 | PubTator, text mining | PubMed |
| Functional E3 ligase hotspots and resistance mechanisms to small-molecule degraders. | Nat Chem Biol | 2023 | 36329119 | PubTator, text mining | PubMed |
| Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors. | Nat Rev Gastroenterol Hepatol | 2023 | 36258033 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non-Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01). | J Clin Oncol | 2023 | 36206498 | PubTator, text mining | PubMed |
| Analysis of SMARCA4 and SMARCA2 Loss in Lung Sarcomatoid Carcinomas. | Turk Patoloji Derg | 2023 | 36178285 | PubTator, text mining | PubMed |
| Epigenetic and pharmacological control of pigmentation via Bromodomain Protein 9 (BRD9). | Pigment Cell Melanoma Res | 2023 | 36112085 | PubTator, text mining | PubMed |
| Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III-IV melanoma in phase III trial E1609. | Qual Life Res | 2023 | 36029412 | PubTator, text mining | PubMed |
| HPV-CCDC106 integration promotes cervical cancer progression by facilitating the high expression of CCDC106 after HPV E6 splicing. | J Med Virol | 2023 | 35854676 | PubTator, text mining | PubMed |
| Epilepsy and Cognitive Impairment in Childhood and Adolescence: A Mini-Review. | Curr Neuropharmacol | 2023 | 35794776 | PubTator, text mining | PubMed |
| A classification of genes involved in normal and delayed male puberty. | Asian J Androl | 2023 | 35532554 | PubTator, text mining | PubMed |
| DriverMP enables improved identification of cancer driver genes. | Gigascience | 2022 | 38091511 | PubTator, text mining | PubMed |
| Antibodies of the immunoglobulin a isotype to novel antigens in early axial spondyloarthritis. | Front Med (Lausanne) | 2022 | 36844956 | PubTator, text mining | PubMed |
| SL-Cloud: A Cloud-based resource to support synthetic lethal interaction discovery. | F1000Res | 2022 | 36761837 | PubTator, text mining | PubMed |
| Synthetic lethal interactions of DEAD/H-box helicases as targets for cancer therapy. | Front Oncol | 2022 | 36761420 | PubTator, text mining | PubMed |
Long-term benefit of immunotherapy in a patient with squamous lung cancer exhibiting mismatch repair deficient/high microsatellite instability/high tumor mutational burden: A case report and literature review. | Front Immunol | 2022 | 36703977 | PubTator, text mining | PubMed |
| Retinal microvasculature observations of fellow eyes after intra-arterial chemotherapy for unilateral retinoblastoma using optical coherence tomography angiography. | Front Med (Lausanne) | 2022 | 36703895 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6595/papers?page=28